Invitrogen™ CRG-L2 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA563723

Catalog No. PIPA563723

Description

Immunogen sequence: ASAPPQDPAS SARNKRSHSG EPAPHIRAES HDMLMMMTYS MVPIRVMVDL CNSTKGICLT GP Highest antigen sequence identity to the following orthologs: Mouse - 81%, Rat - 82%.

CRG-L2 is a protein that contains olfactomedin-like and collagen-like domains. The encoded protein, which exists in both transmembrane and secreted forms, promotes formation of the nodes of Ranvier in the peripheral nervous system. Mutations in this gene cause a form of lethal congenital contracture syndrome in human patients. Autoantibodies to the encoded protein have been identified in sera form patients with multifocal motor neuropathy.

Specifications

• Antigen: CRG-L2
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: Gldn
• Gene Alias: cancer related gene - liver 2; cancer-related gene liver 2 protein; Clom; collomin; COLM; colmedin; Crgl2; CRG-L2; Crlg2; FLJ23917; Gldn; Gliomedin; Gliomedin shedded ectodomain; olfactomedin-related protein; UNC-112; UNQ9339/PRO34011
• Host Species: Rabbit
• Purification Method: Antigen Affinity Chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 342035
• Content And Storage: Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
• Form: Liquid

• Applications: Immunohistochemistry (Paraffin)
• Concentration: 0.1 mg/mL
• Formulation: PBS with 40% glycerol and 0.02% sodium azide; pH 7.2
• Gene Accession No.: Q6ZMI3
• Gene Symbols: Gldn
• Immunogen: Recombinant protein corresponding to Human CRG-L2. Recombinant protein control fragment (Product #RP-103354).
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov